Position in NVO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$878,740
+$202,687 QoQ
Shares Held
18,330
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#555
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banco de Sabadell, S.A holds $14,969,128 across 7 Drug Manufacturers - General names. NVO ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,248 | $5,095,179 | |
| 2 | JNJ |
Johnson & Johnson
|
12,879 | $3,270,879 | |
| 3 | AMGN |
Amgen Inc
|
6,877 | $2,490,299 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,969 | $1,538,016 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
18,330 | $878,740 | |
| 6 | SNY |
Sanofi
|
20,466 | $873,079 | |
| 7 | NVS |
Novartis AG
|
5,251 | $822,936 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $878,740 | 18,330 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $676,053 | 18,396 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $910,752 | 17,900 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $999,541 | 18,013 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,361,902 | 19,732 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,370,190 | 19,732 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,516,274 | 17,627 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,174,456 | 18,262 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,016,524 | 21,133 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,654,156 | 20,671 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,146,794 | 20,752 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,892,097 | 20,806 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,744,203 | 10,778 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,723,008 | 10,827 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,615,553 | 11,937 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,165,471 | 11,698 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,472,770 | 13,217 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,506,837 | 13,569 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,410,416 | 12,593 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,098,066 | 11,437 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,029,030 | 12,284 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $774,116 | 11,482 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,220,824 | 60,427 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,148,510 | 59,751 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,076,915 | 62,262 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $4,794,086 | 79,636 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||